August 21, 2026/
The market demand for affordable, regulator-ready ARV generics continues to grow, yet many molecules remain difficult to formulate and scale. One such molecule, Etravirine, presented thermal sensitivity, solubility and stability hurdles that made conventional approaches risky and resource-intensive. Using STEER’s solvent-free FragMelt™ continuous hot-melt fusion platform, STEERLife applied DoE, defined...
